Go to the USUHS home page

  Our products
  A to Z index
  Contact us

Biodosimetry Tools

Emergency Response Resources
  Advisory team
  Other resources

Managing Radiation Casualties
  Depleted uranium
  Potassium iodide
  Prussian blue
  Radiation patient treatment
  Managing radiological casualties
  Response to nuclear detonation
      • 1st Edition (Jan 2009)
      • 2nd Edition (Jun 2010)
  NCRP recommendations
  Consequences of nuclear warfare

Medical Effects of Ionizing Radiation
  In-person course
  Online course
  Schedule, fees, registration
  Course resources
  » What is ionizing radiation? «
  » Veterans' radiation exposure «

Product Quick List
  Exposure assessment tools

  Books/book chapters
  Contract reports
  Journal articles/supplements
  Reports/report chapters
  Scientific reports
  Special publications
  Technical reports

Register AFRRI Products

Research Programs
  Combined Injury: Radiation with
      Other Insults

  Internal Contamination and
      Metal Toxicity

  Countermeasure Development

2014 AFRRI Seminars

USU Dept. of Radiation Biology
You are here:  HOME  >  Seminars  >  2005 seminar schedule

2005 AFRRI Seminars

Jump to:    2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
Time:  11 a.m. to 12 noon (unless otherwise noted) each Friday
Place:  AFRRI Conference Room, unless otherwise indicated.
Directions to AFRRI  |   Base map  |  Security, base access, parking
Seminars are presented by AFRRI researchers and other members of the scientific community. While some seminars are open to the public, others are limited to specific audiences. Any exceptions to time, place, and admittance are noted with each item. We do not record or distribute information presented in our Seminar Program. However, where available, references to related information are provided with the seminar title.
2005 seminar schedule
  • Friday, December 2: Michael Abend, MD, PhD, deputy director and group leader, “Radiation Epidemiology,” Institute of Radiobiology of the German Armed Forces, Munich, Germany: Correcting false gene expression measurements from degraded RNA using RTQ-PCR.
  • Friday, November 18: Alexandra C. Miller, PhD, Scientific Research Department, AFRRI: Deleted uranium and transgenerational effects: A review of preconceptional paternal exposure to radiation, heavy metals, and current studies.
  • Friday, October 21: Terry Pellmar, PhD, Scientific Director, AFRRI: Transformation of the science directorate.
  • Friday, September 30: Pataje G.S. Prasanna, PhD, Biodosimetry Team, AFRRI: Cytogenetic biodosimetry laboratory automation and laboratory information management system.
  • Friday, September 16: Scott A. Wilson, MAJ, USA, assistant joint product manager, Medical Identification and Treatment Systems, Chemical Biological Medical Systems, Joint Program Executive Office for Chemical/Biological Defense, Frederick, MD: Department of Defense acquisition overview.
  • Friday, September 9: Pawan Sharma, PhD, senior research scientist, Immunology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India: Modulation of dendritic cells by mycobacterial secretory protein.
  • Thursday, September 1: C.K.K. Nair, Head, Radiation Biochemistry Section, Radiation Biology and Health Science Division, Bhabha Atomic Research Centre, Mumbai, India: Natural and synthetic drugs with potential for radioprotection in humans.
  • Thursday, July 28: Cameron Koch, MD, Radiation Biology Branch, Department of Radiation Oncology, UPENN, Philadelphia: Oxygen and its interaction with radioprotectors.
  • Friday, July 22: Charles A. Salter, LTC, USA, Biodosimetry Team, AFRRI: Presenting radiation casualty management at a military medicine conference in Vietnam.
  • Friday, July 1 (DoD only): K. Sree Kumar, PhD, Radiation Casualty Management Team, AFRRI: Radioprotection by tocols: Role of cytokine induction.
  • Friday, June 24 (DoD only): Mark H. Whitnall, PhD, Radiation Casualty Management Team, AFRRI: Evaluation and development of radiation countermeasures at AFRRI.
  • Friday, May 27: Glen L. Manglapus, CPT, USA, Biodosimetry Team, AFRRI: Transcriptional regulators of progenitor cells in the rat olfactory epithelium.
  • Friday, May 20: Andreas M. Papas, PhD, president, YASOO Health, Inc., Johnson City, TN: Vitamin E: A new perspective.
  • Friday, April 29 (DoD only): Alexandra Miller, PhD, Radiation Casualty Management Team, AFRRI: Chemoprevention of radiation-induced cancer: Development of a molecular biomarker-based strategy.
  • Thursday, April 28: Bobby R. Scott, PhD, Lovelace Respiratory Research Institute, Albuquerque, NM: Residual risks for lethality after application of medical countermeasures against damage from inhaled γ-emitting radionuclides released from a radiological weapon.
  • Friday, April 22 (DoD only): Michael O. Shoemaker, PhD, Research Microbiologist/Pharmacologist, Radiation Infection Treatment Team, AFRRI: Antimicrobial efficacy of ciprofloxacin and genistein: Preliminary studies.
  • Friday, April 8: Juliann G. Kiang, PhD, Professor of Medicine and Pharmacology, Walter Reed Army Institute of Research (WRAIR) and USUHS: Geldanamycin inhibits apoptosis in organs of hemorrhaged mice: iNOS, caspase-3, ATP.
  • Friday, March 25 (DoD only): Venkataraman Srinivasan, PhD, Research Biologist, Radiation Casualty Management Team, AFRRI: Evaluation of non-toxic agents and drugs as radioprotectants in mice.
  • Friday, March 18 (DoD only): Gregory L. King, PhD, Research Physiologist, Radiation Infection Treatment Team, AFRRI: Probiotic plus antibiotic treatment for γ-irradiated and infected mice: Preliminary studies.
  • Friday, March 4 (DoD only): R. Joel Lowry, PhD, Radiation Infection Treatment Team, AFRRI: Virus infection and radiation—Puzzling the pathways.
  • Tuesday, March 1: Len Connell, PhD, and Lawrence Trost, PhD, National Security Studies Department, Sandia National Laboratories, Albuquerque, NM: A risk-based approach to RDD (radiation dispersal device) threat analysis.
  • Friday, February 25 (DoD only): John F. Kalinich, PhD, Research Biochemist, Heavy Metals Research Team, AFRRI: Development of a colorimetric test for uranium.
  • Friday, February 18 (DoD only): William F. Blakely, PhD, Team Leader, Biodosimetry Team, AFRRI: Biological dosimetry team research and service program.
  • Friday, February 11: Itzhak Brook, CDR, USN, Research Infection Treatment Team, AFRRI: Effect of nuclear detonations on large biological specimens (swine). Results of Operation Plumbob—1957.
  • Friday, February 4 (DoD only): Michael R. Landauer, PhD, Research Toxicologist, Radiation Casualty Management Team, AFRRI: Radioprotective efficacy of soy isoflavones.
  • Friday, January 28 (DoD only): Marcy Grace, PhD, Research Molecular Biologist, Biodosimetry Team, AFRRI: Candidate gene-expression biomarker assay validation and biodosimeter instrumentation.
  • Friday, January 21 (DoD only): G. David Ledney, PhD, Acting Team Leader, Radiation Infection Treatment Team, AFRRI: Combined injury: Past, present, and the future.
  • Friday, January 14 (DoD only): Thomas B. Elliott, PhD, Research Microbiologist, Radiation Infection Treatment Team, AFRRI: Research objectives of the revised RIT DTO.
  • Friday, January 7: David E. McClain, PhD, Team Leader, Heavy Metals Research Team, AFRRI: Research objectives and projects of the AFRRI Heavy Metals Research Team.